Pasithea Therapeutics Corp. · NASDAQ:KTTA

Squadron Capital Management LLC reported a 9.90% stake in Pasithea Therapeutics Corp. (Schedule 13G/A)

Event Dec 31, 2025 · Filed Feb 17, 2026

Squadron Capital Management LLC reported a 9.90% stake in Pasithea Therapeutics Corp., 2,329,749 shares, as a passive investor on Dec 31, 2025. Filed Feb 17, 2026 (Schedule 13G/A).

Stake
9.90%
Shares
2,329,749
Intent
Passive
What changed
Stake changed
Filed together
4 holders

The filing in full

HolderStakeShares
Squadron Master Fund LP9.90%2,329,749
Squadron Capital Management LLC9.90%2,329,749
Matthew Sesterhenn9.90%2,329,749
William Blank9.90%2,329,749

Source

View original at SEC

Related